The European Union health agency said the Covid-19 vaccine produced by AstraZeneca PLC was “safe and effective” and did not increase the risk of blood clots, a decision that could pave the way for the resumption of inoculation campaigns that have stopped. in much of the region.
The European Medicines Agency said a new expert analysis concluded that the benefits of using a Covid-19 vaccine produced by AstraZeneca outweigh its potential risks and should be inoculated into it.
EU authorities hope that the EMA’s statement can re-launch a trouble-free vaccination campaign, although it remains to be seen whether the new analysis will overcome the distrust of AstraZeneca’s shooting among many Europeans.
Many European countries, including Germany, France and Italy, stopped using the vaccine last week after reporting that people who had received it developed rare blood clots and that some had died, which it further slowed down Europe’s already slow vaccination exercise.
These reports exacerbated delays and uncertainties about an impetus that has left the EU far behind the US and UK in vaccinating its citizens.